
Sign up to save your podcasts
Or


President Trump’s nominee for NIH director extolled the importance of transparency—just days after HHS rescinded a Nixon-era policy intended to enhance it.
Paul Goldberg, editor and publisher of The Cancer Letter, and Jacquelyn Cobb, associate editor, discuss Jayanta Bhattacharya’s stance on the mass firings sweeping through HHS, Trump’s proposed cap on indirect costs, and more this week on The Cancer Letter Podcast.
During his confirmation hearing before the members of the Health, Education, Labor, and Pensions Committee March 5, Bhattacharya listed his five primary goals at NIH:
Chronic disease
Reliability
Scientific dissent
Innovation
Regulation of gain-of-function research
As for the questions on everybody’s minds:
When asked about mass firings, Bhattachharya said he has no intention of firing anyone at NIH.
And in regards to indirect costs, Bhattachharya does not think the system needs to be reworked. Instead, he believes increased transparency, including audits of university spending of indirect costs, would help reduce distrust about where the money goes.
Other stories mentioned in this podcast include:
Survey reveals most Americans are uninformed about HPV. A vaccine can prevent cancer—most people don’t take it
Column from former NCI Director Kimryn Rathmell: Raising awareness—for everyone
Regeneron Science Talent Search finalists press on at a time of uncertainty
Guest editorial by Michael P. Castro: The new therapeutic imperative in cancer management: Sequence, biosimulate, treat
Fred Hutch marks “50 years of doing hard things”
A transcript of this podcast is available: https://cancerletter.com/podcastc/20250312-bhattacharya/
By The Cancer LetterPresident Trump’s nominee for NIH director extolled the importance of transparency—just days after HHS rescinded a Nixon-era policy intended to enhance it.
Paul Goldberg, editor and publisher of The Cancer Letter, and Jacquelyn Cobb, associate editor, discuss Jayanta Bhattacharya’s stance on the mass firings sweeping through HHS, Trump’s proposed cap on indirect costs, and more this week on The Cancer Letter Podcast.
During his confirmation hearing before the members of the Health, Education, Labor, and Pensions Committee March 5, Bhattacharya listed his five primary goals at NIH:
Chronic disease
Reliability
Scientific dissent
Innovation
Regulation of gain-of-function research
As for the questions on everybody’s minds:
When asked about mass firings, Bhattachharya said he has no intention of firing anyone at NIH.
And in regards to indirect costs, Bhattachharya does not think the system needs to be reworked. Instead, he believes increased transparency, including audits of university spending of indirect costs, would help reduce distrust about where the money goes.
Other stories mentioned in this podcast include:
Survey reveals most Americans are uninformed about HPV. A vaccine can prevent cancer—most people don’t take it
Column from former NCI Director Kimryn Rathmell: Raising awareness—for everyone
Regeneron Science Talent Search finalists press on at a time of uncertainty
Guest editorial by Michael P. Castro: The new therapeutic imperative in cancer management: Sequence, biosimulate, treat
Fred Hutch marks “50 years of doing hard things”
A transcript of this podcast is available: https://cancerletter.com/podcastc/20250312-bhattacharya/